David Persing

BioTech

Harnessing molecular diagnostics to address antibiotic shortages

Editor’s Note: David Persing, chief medical and scientific officer at Cepheid, a Danaher operating company, is an expert on molecular diagnostics and anti-microbial resistance. He has spent

David Persing August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

David Persing

Harnessing molecular diagnostics to address antibiotic shortages

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe